The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer
Open accessAbstract
H19 is an imprinted oncofetal non-coding RNA recently shown to be the precursor of miR-675. The pathophysiological roles of H19 and its mature product miR-675 to carcinogenesis have, however, not been defined. By quantitative reverse transcription-polymerase chain reaction, both H19 and miR-675 were found to be upregulated in human colon cancer cell lines and primary human colorectal cancer (CRC) tissues compared with adjacent non-cancerous tissues. Subsequently, the tumor suppressor retinoblastoma (RB) was confirmed to be a direct target of miR-675 as the microRNA suppressed the activity of the luciferase reporter carrying the 3'-untranslated region of RB messenger RNA that contains the miR-675-binding site. Suppression of miR-675 by transfection with anti-miR-675 increased RB expression and at the same time, decreased cell growth and soft agar colony formation in human colon cancer cells. Reciprocally, enhanced miR-675 expression by transfection with miR-675 precursor decreased RB expression, increased tumor cell growth and soft agar colony formation. Moreover, the inverse relationship between the expressions of RB and H19/miR-675 was also revealed in human CRC tissues and colon cancer cell lines. Our findings demonstrate that H19-derived miR-675, through downregulation of its target RB, regulates the CRC development and thus may serve as a potential target for CRC therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Wightman, B., Ha, I., & Ruvkun, G. (1993) · Cell · doi:10.1016/0092-8674(93)90530-4 · Cited by 4,292
RAS Is Regulated by the let-7 MicroRNA Family
Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,656
miR-15 and miR-16 induce apoptosis by targeting BCL2
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,517
A microRNA polycistron as a potential human oncogene
He, L., Thomson, J. M., Hemann, M. T., Hernando-Monge, E., Mu, D., Goodson, S., Powers, S., Cordon-Cardo, C., Lowe, S. W., Hannon, G. J., et al. (2005) · Nature · doi:10.1038/nature03552 · Cited by 3,483
microRNAs as oncogenes and tumor suppressors
Zhang, B., Pan, X., Cobb, G. P., & Anderson, T. A. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2006.08.028 · Cited by 2,749
RNAhybrid: microRNA target prediction easy, fast and flexible
Kruger, J., & Rehmsmeier, M. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl243 · Cited by 1,941
Reduced accumulation of specific microRNAs in colorectal neoplasia.
Michael, M., Connor, S. M. O., Pellekaan, N. V. H., Young, G. P., & James, R. J. (2003) · PubMed · Cited by 1,775
Cited by
The functional role of long non-coding RNA in human carcinomas
Gibb, E. A., Brown, C. J., & Lam, W. L. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-38 · Cited by 1,619
Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer
Mármol, I., Sánchez-de-Diego, C., Pradilla Dieste, A., Cerrada, E., & Rodriguez Yoldi, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010197 · Cited by 1,525
Long non-coding RNAs and cancer: a new frontier of translational research?
Spizzo, R., Almeida, M. I., Colombatti, A., & Calin, G. A. (2012) · Oncogene · doi:10.1038/onc.2011.621 · Cited by 1,004
Ren, J., Ding, L., Zhang, D., Shi, G., Xu, Q., Shen, S., Wang, Y., Wang, T., & Hou, Y. (2018) · Theranostics · doi:10.7150/thno.25541 · Cited by 698
Therapeutic Targeting of Long Non-Coding RNAs in Cancer
Arun, G., Diermeier, S. D., & Spector, D. L. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.01.001 · Cited by 611
Liang, W.-C., Fu, W.-M., Wong, C.-W., Wang, Y., Wang, W.-M., Hu, G.-X., Zhang, L., Xiao, L.-J., Wan, D. C.-C., Zhang, J.-F., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4154 · Cited by 571
Raveh, E., Matouk, I. J., Gilon, M., & Hochberg, A. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0458-2 · Cited by 525
Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer
Li, H., Yu, B., Li, J., Su, L., Yan, M., Zhu, Z., & Liu, B. (2014) · Oncotarget · doi:10.18632/oncotarget.1913 · Cited by 508
The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine
Qi, P., & Du, X. (2013) · Modern Pathology · doi:10.1038/modpathol.2012.160 · Cited by 506
Wang, F., Yuan, J.-H., Wang, S.-B., Yang, F., Yuan, S.-X., Ye, C., Yang, N., Zhou, W.-P., Li, W.-L., Li, W., et al. (2014) · Hepatology · doi:10.1002/hep.27239 · Cited by 440
Hauptman, N., & Glavač, D. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14034655 · Cited by 349
Zhang, L., Yang, F., Yuan, J.-H., Yuan, S.-X., Zhou, W.-P., Huo, X.-S., Xu, D., Bi, H.-S., Wang, F., & Sun, S.-H. (2013) · Carcinogenesis · doi:10.1093/carcin/bgs381 · Cited by 334
Interaction and cross-talk between non-coding RNAs
Yamamura, S., Imai-Sumida, M., Tanaka, Y., & Dahiya, R. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2626-6 · Cited by 302
lnc RNA H19/miR‐675 axis represses prostate cancer metastasis by targeting TGFBI
Zhu, M., Chen, Q., Liu, X., Sun, Q., Zhao, X., Deng, R., Wang, Y., Huang, J., Xu, M., Yan, J., et al. (2014) · The FEBS Journal · doi:10.1111/febs.12902 · Cited by 299
Self-citationRegulation of lncRNA and Its Role in Cancer Metastasis
Li, J., Meng, H., Bai, Y., & Wang, K. (2016) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504016x14549667334007 · Cited by 297
Long Non-Coding RNA H19 Promotes Glioma Cell Invasion by Deriving miR-675
Shi, Y., Wang, Y., Luan, W., Wang, P., Tao, T., Zhang, J., Qian, J., Liu, N., & You, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086295 · Cited by 287
Cell cycle regulation by long non-coding RNAs
Kitagawa, M., Kitagawa, K., Kotake, Y., Niida, H., & Ohhata, T. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1423-0 · Cited by 278
Long noncoding RNAs: a potential novel class of cancer biomarkers
Yarmishyn, A. A., & Kurochkin, I. V. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00145 · Cited by 273
Epigenetics of Colorectal Cancer
Goel, A., & Boland, C. R. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.09.032 · Cited by 273
From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis
Dhamija, S., & Diederichs, S. (2016) · International Journal of Cancer · doi:10.1002/ijc.30039 · Cited by 272
The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy
Wang, J., Xie, S., Yang, J., Xiong, H., Jia, Y., Zhou, Y., Chen, Y., Ying, X., Chen, C., Ye, C., et al. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0747-0 · Cited by 264
GAMBARI, R., BROGNARA, E., SPANDIDOS, D. A., & FABBRI, E. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3503 · Cited by 262
Long Noncoding RNAs in Cancer: From Function to Translation
Sahu, A., Singhal, U., & Chinnaiyan, A. M. (2015) · Trends in Cancer · doi:10.1016/j.trecan.2015.08.010 · Cited by 260
Long Noncoding RNAs in Cancer and Therapeutic Potential
Renganathan, A., & Felley-Bosco, E. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-10-5203-3_7 · Cited by 260
The role of microRNAs in colorectal cancer
Schetter, A. J., Okayama, H., & Harris, C. C. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e318258b78f · Cited by 252
Metformin alters DNA methylation genome-wide via the H19/SAHH axis
Zhong, T., Men, Y., Lu, L., Geng, T., Zhou, J., Mitsuhashi, A., Shozu, M., Maihle, N. J., Carmichael, G. G., Taylor, H. S., et al. (2017) · Oncogene · doi:10.1038/onc.2016.391 · Cited by 151
Wang, G., Lunardi, A., Zhang, J., Chen, Z., Ala, U., Webster, K. A., Tay, Y., Gonzalez-Billalabeitia, E., Egia, A., Shaffer, D. R., et al. (2013) · Nature Genetics · doi:10.1038/ng.2654 · Cited by 137
“Given that miR-675 is known to target the tumor suppressor retinoblastoma ( Rb ) 46 , a key regulator of the cellular senescence response 47 , we tested whether miR-675 expression was concomitantly increased in Pten and Zbtb7a double-mutant mice.”
MicroRNA as an Important Target for Anticancer Drug Development
Fu, Z., Wang, L., Li, S., Chen, F., Au-Yeung, K. K.-W., & Shi, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.736323 · Cited by 133
Cai, B., Ma, W., Bi, C., Yang, F., Zhang, L., Han, Z., Huang, Q., Ding, F., Li, Y., Yan, G., et al. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12331 · Cited by 98
Xiao, X., Zhu, W., Liao, B., Xu, J., Gu, C., Ji, B., Yao, Y., Peng, L., & Yang, J. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00411 · Cited by 47
The regulatory role of miRNAs on VDR in breast cancer
Singh, T., & Adams, B. D. (2017) · Transcription · doi:10.1080/21541264.2017.1317695 · Cited by 37
“Additional miRNA interactions involved in breast cancer include miR-627 and JMJD1A, and miR-125b and NCOR2/SMRT.57,74 In the miRNA field, bioinformatic tools such as TargetScan, a software program that provides prediction of the targets of miRNAs, have immensely helped in advancing the field.25 We wanted to determine…”
BackgroundHabieb, A., Matboli, M., El-Tayeb, H., & El-Asmar, F. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-04810-x · Cited by 29
Metadata
- Authors
- Tsang, W. P., Ng, E. K. O., Ng, S. S. M., Jin, H., Yu, J., Sung, J. J. Y., & Kwok, T. T.
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-11-19
- Volume
- 31
- Issue
- 3
- Pages
- 350-358
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- OpenAlex
- W2111047063
- Cited by
- 456
- References
- 38
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.